News

Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...
Novo Nordisk, a leading global healthcare company, has announced the signing of a MoU with Lifera, a biopharmaceutical company owned by the Saudi sovereign wealth fund PIF (Public Investment Fund), to ...
April 24, 2025. More for You ...
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
Seizures of potentially dangerous weight loss drugs being sold on the black market in Scotland have soared as online dealers ...
Health and wellness influencer Janelle Rohner has been using a GLP-1 medication to lose weight. “This isn't easy to say, but ...
Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...
Drugs like Ozempic and Wegovy can have a surprising impact on the brain, suggesting potential new avenues of research and ...
Years ago, Robyn Munsch would wander hungrily around the grocery store and leave with calorie-dense foods like a frozen pizza ...
Novo Nordisk remains financially strong, but pricing pressures and CagriSema challenges limit near-term upside. Find out why ...
Trending weight loss drugs such as Ozempic and Wegovy may be highly effective at tackling obesity, but are they also carrying ...
This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...